ClinicalTrials.gg
CompletedNCT02832453BELLUGATUpdated Aug 21, 2019

Metabolic Risk Management, Physical Exercise and Lifestyle Counselling in Low-active Adults; Controlled Randomized Trial

An interventional study of Lifestyle and Aerobic interval training in Metabolic Syndrome X, Lifestyle-related Condition and Lifestyle Risk Reduction, sponsored by INEFC-Lleida. Completed at 1 site in Spain. Open to participants aged 30 Years to 52 Years. Per ClinicalTrials.gov, last updated 2019-08-21.

Sponsored by INEFC-Lleida · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
30 Years to 52 Years
Sex
All
01

Study summary

The purpose of this study is evaluate the effectiveness of different doses of supervised exercise training intensity -concomitant to lifestyle counselling- as a Primary Health Care intervention tool for the management of the metabolic syndrome in low active adults with one or more metabolic risk factors.

Secondary aims of the study are to investigate the effects of these interventions on systemic inflammation and adipose tissue function, cardiorespiratory fitness, physical activity and sedentary habits, and the cost-effectiveness of the intervention with regard to health related quality of life.

The general hypothesis is that adults with risk factors for metabolic syndrome participating in interventions for the promotion of a healthy lifestyle that together with counselling strategies will include supervised physical exercise of vigorous intensity will present greater improvements in terms of metabolic risk, physical condition, physical activity/sedentary behaviours and psychological parameters at the end of the intervention and at 6-months follow-up than participants in interventions for the promotion of a healthy lifestyle that will include counselling plus physical exercise of low-to-moderate intensity or interventions based exclusively on counselling.

It is a three arms controlled randomized clinical trial implemented in the Primary Health Care setting and of 10 months duration.

Read the detailed description

The purpose of this study is evaluate the effectiveness of different doses of supervised exercise training intensity -concomitant to lifestyle counselling- as a Primary Health Care intervention tool for the management of the metabolic syndrome in low active adults with one or more metabolic risk factors.

Secondary aims of the study are to investigate the effects of these interventions on systemic inflammation and adipose tissue function, cardiorespiratory fitness, physical activity and sedentary habits, and the cost-effectiveness of the intervention with regard to health related quality of life.

The general hypothesis is that adults with risk factors for metabolic syndrome participating in interventions for the promotion of a healthy lifestyle that together with counselling strategies will include supervised physical exercise of vigorous intensity will present greater improvements in terms of metabolic risk, physical condition, physical activity/sedentary behaviours and psychological parameters at the end of the intervention and at 6-months follow-up than participants in interventions for the promotion of a healthy lifestyle that will include counselling plus physical exercise of low-to-moderate intensity or interventions based exclusively on counselling.

It is a three arms controlled randomized clinical trial implemented in the Primary Health Care setting and of 10 months duration.

Adults aged 30 to 52 years with metabolic risk factors will be randomized in three intervention groups that will be given one of the following: assessment on healthy lifestyle plus high intensity physical exercise supervision (3 individual and 6 group sessions + 16 supervised training lessons); assessment plus low-to-moderate intensity physical exercise supervision (3 individual and 6 group sessions + 16 supervised training lessons) or assessment-based programme without physical exercise supervision (3 individual and 6 group sessions).

The main output variables evaluated will be: a) risk factors for the metabolic syndrome (waist circumference, blood pressure, and plasma triglycerides, high density lipoproteins and glucose), systemic inflammation and adipose tissue functionality, physical activity habits and sedentary conducts, dietary habits, quality of life related to health, self-efficacy and empowerment. The economic cost will also be analysed to determine the cost-effectiveness of the program. These variables will be assessed 3 times alongside the study: at baseline, at the end of the 4 months intervention, and at 6 months follow-up. It has been estimated to recruit 33 participants per group, which are 100 participants.

02

Conditions studied

  • Metabolic Syndrome X
  • Lifestyle-related Condition
  • Lifestyle Risk Reduction
  • Cardiovascular Risk Factor

Keywords

  • High intensity physical exercise
  • Primary health care
  • Behaviour change interventions
03

In context

Metabolic Syndrome

2,011 studies on the registry are indexed under Metabolic Syndrome; 334 are open to participants now.

This study's enrollment of 77 is above the median of 60 across 1,494 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

This is the only study on the registry with INEFC-Lleida as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 52 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Low active (achieving less than 150 minutes/week of moderate-to-vigorous physical activity or have not participated in any supervised exercise programs for at least the last 6 months).
  • Having one or more risk factors for metabolic syndrome (Marcuello et al., 2013) (waist circumference >94.5 cm for men and >89.5 cm for women; blood pressure ≥130/85 mmHg; triglycerides in plasma ≥150 mg/dL; high density lipoprotein cholesterol in plasma \<40 mg/dL for men and \<50 mg/dL for women; fasting glycaemia ≥100 mg/dL).
  • Accept and sign the written informed consent.
  • Accept the randomized group assignment.

Exclusion criteria

Exclusion Criteria:

  • Couples or individuals living in the same house
  • Morbid obesity (BMI ≥ 40).
  • A past/current history and/or physical examination or laboratory findings of significant diseases of cardiovascular, respiratory, neuromuscular, psychiatric diseases/disorders.
  • Diseases/disorders that may contraindicate performing physical exercise or a stress test.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
77 participants (actual)

Study arms

  • Other
    Lifestyle counseling

    This group will receive lifestyle counselling but not supervised exercise training sessions

    Behavioral: Lifestyle

  • Experimental
    Aerobic interval training

    This group will receive lifestyle counselling plus supervised high intensity (80%VO2max) interval exercise training sessions

    Behavioral: Lifestyle · Behavioral: Aerobic interval training

  • Active comparator
    Traditional continous training

    This group will receive lifestyle counselling plus supervised moderate intensity (60%VO2max) continous exercise training sessions

    Behavioral: Lifestyle · Behavioral: Traditional continous training

Interventions

  • BehavioralLifestyle

    The counselling program consists of 6 group meetings of 1 hour and 3 individual consultations of at least 15 minutes each. Sessions will be set up with the aim to enhance knowledge and empowerment related to physical activity, sedentary conducts, dietary habits, as well as strategies for behaviour change will be given. Individual consultations will focus on establishing realistic objectives and to involve the participants in taking decisions.

  • BehavioralAerobic interval training

    The supervised aerobic interval training will consist of 16 supervised group training lessons lasting 60 minutes and 32 individual nonsupervised training lessons that would be self-administered by each participant. The main part of the training lessons will consist of 4 series of 4 minutes of cycling at a heart rate of 80% of the VO2peak interspersed with active pauses of 2 minutes at 60% of the VO2peak .

  • BehavioralTraditional continous training

    The supervised traditional continous training will consist of 16 supervised group training lessons lasting 60 minutes and 32 individual nonsupervised training lessons that would be self-administered by each participant. The main part of the training lessons will consist of activities such as walking, cycling, or tonification exercises always at an intensity of 60% of the VO2peak.

06

What researchers measure

Primary outcomes

  1. Change from baseline in metabolic risc score

    A continuous metabolic syndrome risk score (cMSSy) will be calculated as described by Wijndaele (Wijndaele et al., 2006). The score contains the five risk factors considered in the definition of the metabolic syndrome (Expert panel on detection, 2001; Marcuello et al., 2013), that is waist circumference, triglycerides, high density lipoproteins cholesterol, systolic blood pressure and plasma glucose.

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

Secondary outcomes

  1. Change from baseline in cardiorespiratory fitness

    Improvement of peak oxygen uptake (VO2peak). Cardiorespiratory fitness will be assessed by means of voluntary maximal graded exercise on a cycle ergometer while measuring oxygen consumption (VO2).

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  2. Change from baseline in active lifestyle

    Daily time spent at moderate-to-vigorous physical activity. Participants will wear Actigraph accelerometers (GT3X+ models) during all day for seven consecutive days. Cut points for moderate-to-vigorous physical activity will be set above 2020 counts per minute.

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  3. Change from baseline in sedentary time

    Reduction of the daily time devoted to sedentary conducts. Participants will wear Actigraph accelerometers (GT3X+ models) during all day for seven consecutive days. Cut points for sedentary conducts will be set under 100 counts per minute.

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  4. Change from baseline in dietary habits

    Improvement of healthy eating index

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  5. Change from baseline in physical activity self-efficacy questionnaire

    Spanish version of the physical activity scale (Fernández-Cabrera, Medina, Rueda, Ordoñez, \& León, 2012)

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  6. Change from baseline in empowerment

    Health Empowerment Scale (HES) (Serrani, 2014)

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  7. Change from baseline in health related quality of life at the end of the intervention

    Quality of life questionaire (EQ-5D)

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  8. Change from baseline in health related quality of life

    Quality of life questionaire (EQ-5D)

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  9. Change from baseline in interleucin-6

    Fasting blood samples will be drawn to determine interleukin by cytometry.

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  10. Change from baseline in adiponectin

    Fasting blood samples will be drawn to determine adiponectin by cytometry.

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

  11. Change from baseline in plasma metabolome

    Fasting blood samples will be drawn to determine plasma metabolome.

    Time frame: 3 time points: at baseline, 4 months (end of the intervention) and at 6 months after the end of the intervention.

Other outcomes

  1. Cost-effectiveness of the intervention

    Direct and indirect costs of setting and running the interventions will be collected for the economic evaluation analysis by means of questionnaires. HRQoL scores will be used to weight survival years and generate quality adjusted life years (QALYs ). The cost-effectiveness analysis will be conducted according to the current practice methods for economic evaluation (Frew et al., 2014).

    Time frame: 4 months

07

Study locations

1 site
  • INEFC-Lleida
    Lleida, 25192, Spain
08

References and documents

Publications

  • Ensenyat A, Espigares-Tribo G, Machado-Da-Silva L, Sinfreu-Bergues X, Blanco A. Semisupervised Physical Exercise and Lifestyle Counseling in Cardiometabolic Risk Management in Sedentary Adults: Controlled Randomized Trial (BELLUGAT). J Phys Act Health. 2020 Jun 12;17(7):744-755. doi: 10.1123/jpah.2019-0409. PubMed 32531762 ↗
  • Ensenyat A, Espigares-Tribo G, Machado L, Verdejo FJ, Rodriguez-Arregui R, Serrano J, Miret M, Galindo G, Blanco A, Marsal JR, Sarriegui S, Sinfreu-Bergues X, Serra-Paya N. Metabolic risk management, physical exercise and lifestyle counselling in low-active adults: controlled randomized trial (BELLUGAT). BMC Public Health. 2017 Mar 14;17(1):257. doi: 10.1186/s12889-017-4144-8. PubMed 28292282 ↗

Individual participant data

Plan to share: Undecided — At present we have not planned to share data. Probably at the end of the trail we will put them on the repository of the University of Lleida.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02832453
Lead sponsor
INEFC-Lleida
Collaborators
Institut Català de la Salut, Universitat de Lleida, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Responsible party
Assumpta Ensenyat (Dr Assumpta Ensenyat (MD, PhD) Exercise Physiology, INEFC-Lleida) — Principal investigator
First posted
Jul 14, 2016
Start date
Feb 2016
Primary completion
Jun 2017
Completion
Dec 31, 2017
Last update
Aug 21, 2019

Study contacts

Assumpta Ensenyat, MD, PhD
principal investigator · INEFC-Lleida

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion